| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.99 |
| Minerals |
0 |
0.53 |
| Biomarker |
0 |
0.38 |
| Coronary Artery Disease (CAD) |
0 |
0.37 |
| Atrial Fibrillation |
0 |
0.36 |
| Generics |
0 |
0.3 |
| Statins |
0 |
0.3 |
| Fish Oil |
0 |
0.23 |
| Heart |
0 |
0.23 |
| LDL Cholesterol |
0 |
0.23 |
| Triglycerides |
0 |
0.23 |
| Healthcare and Medical Technology |
0 |
0.17 |
| Cardiovascular disease |
0 |
0.15 |
| Clinical Research |
0 |
0.15 |
| Diet |
0 |
0.15 |
| Fatty Acids |
0 |
0.15 |
| Revenue and Practice Management |
0 |
0.15 |
| Atherosclerosis |
0 |
0.13 |
| Apolipoproteins |
0 |
0.08 |
| Artery |
0 |
0.08 |
| Clinical Guidelines |
0 |
0.08 |
| Corns |
0 |
0.08 |
| Drug Costs |
0 |
0.08 |
| Epidemiology |
0 |
0.08 |
| Europe |
0 |
0.08 |
| Exercise |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Hypertriglyceridemia |
0 |
0.08 |
| Insurance |
0 |
0.08 |
| Meta-Analysis |
0 |
0.08 |
| New York |
0 |
0.08 |
| Plasma |
0 |
0.08 |
| UK Site Content |
0 |
0.08 |